Navigation Links
Sensortech Announces New, Ligament Balancing TKA Smart Insert

PENDLETON, S.C., Feb. 6, 2013 /PRNewswire/ -- Sensortech Corporation announced advancement of their new, orthopedic knee alignment product, the Force Check Knee Replacement Smart Insert designed for improving total knee arthroplasty (TKA) surgeries.

Incorporating FDA-approved Bluetooth 4 low energy technology, and FDA-approved plastics technology, the Force Check Knee Replacement Smart Insert can readily adapt to all TKA replacement components on the market. The insert will increase TKA profitability through reduced operating and patient recovery times, faster healing times, reduced component wear, superior pain management and fewer revisions.

With FDA approval, Sensortech's technology could also become a "leave in" device, measuring TKA component performance throughout the replacement's operational life. 

 "The new Smart Insert is a patented, superior solution. It provides real time condyle contact pressure (force) as well as contact location and contact patch movement tracking throughout the flexion test—something unique to the market today. We know the demand for this device is there.  Surgeons and medical device manufacturers have been telling us they need our insert," said inventor Dr. Andrew Clark .

To exploit the market value of this device and assist in acquiring a 510K to develop the "leave in" solution, Sensortech is seeking acquisition partner(s).  The company has also positioned their Force Check Knee Replacement Smart Insert device as an initial entry into a line of medical device smart inserts for all types of joint replacement surgeries.  For more information about Sensortech go to or contact Sensor Tech Corporation at, (864) 298-0684.

This press release includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties. Actual results for fiscal year 2013 and beyond could differ materially from Sensortech Corporation's current expectations. Factors that could cause Sensortech Corporation's results to differ materially from those expressed in forward-looking statements include: variation in demand and acceptance of products and services, general business and economic conditions beyond Sensortech Corporation's control, the consequences of competitive factors in the marketplace including the ability to attract and retain customers, results of continuous improvement and other cost-containment strategies, and Sensortech Corporation's success in attracting and retaining key personnel. Sensortech Corporation undertakes no obligation to revise or update forward-looking statements as a result of new information, since these statements may no longer be accurate or timely.

SOURCE Sensortech Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Emerald Logic announces collaboration with Kings College London on quantitative biomarker discovery
2. Uroplasty Announces Executive Changes In US Sales Organization
3. Akorn, Inc. Announces Fourth Quarter 2012 Earnings Release And Conference Call Information
4. Blue Belt Technologies Announces Hiring of U.S. Commercial Leadership Team
5. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
6. MGC Diagnostics Corporation Announces National Jewish Health Selects the Company as Preferred Provider for Cardiopulmonary Diagnostic Instrumentation
7. Organovo Holdings, Inc. announces redemption of 2.9 million outstanding warrants
8. China Botanic Pharmaceutical Inc. Announces Receipt of Notice of Failure to Satisfy Continued Listing Requirements
9. BD Announces Results for 2013 First Fiscal Quarter
10. Hologic Announces First Quarter Fiscal 2013 Operating Results
11. Cyberonics Announces Update On Hagerty Lawsuit
Post Your Comments:
(Date:12/1/2015)... 1, 2015   MabVax Therapeutics Holdings, Inc . ... it has filed an Investigational New Drug Application (IND) ... the Company,s lead fully human antibody product HuMab 5B1 ... plans to initiate the Phase I clinical trial early ... --> The planned Phase I trial will evaluate ...
(Date:12/1/2015)... , Dec. 1, 2015   Craneware, Inc ... cycle solutions, today announced the company will showcase ... ChargeLink ® solution at the American ... Clinical Meeting . The new features are focused ... of monitoring and managing enterprise-wide pharmacy charges to ...
(Date:12/1/2015)... , Dec. 01, 2015 ... of the "Medical Alert Systems/Personal Emergency Response ... by Geography - Global Forecas" report to ... announced the addition of the "Medical Alert ... by End-User and by Geography - Global Forecas" ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... The Multiple System Atrophy Coalition has announced the launch of ... (MSA) research, timed today to coincide with Giving Tuesday 2015, a global day of ... to work and be productive, to do simple daily activities like walking to the ...
(Date:12/1/2015)... ME (PRWEB) , ... December 01, 2015 , ... Royal ... reports a new study that found post-menopausal women who took the nutritional supplement creatine, ... than women who trained but did not take creatine. , The report is part ...
(Date:12/1/2015)... Fla. (PRWEB) , ... December 01, 2015 , ... ... number of leadless pacemakers in the U.S. and is the only hospital in ... from the largest clinical data presentation of transcatheter pacing patients were revealed recently ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, ... expansion of the company’s growing product line of food safety and seafood fraud ... Sockeye (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification for ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic ... United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a ... catastrophic contributors to diseases of the diabetic foot. The American Board of ...
Breaking Medicine News(10 mins):